日本厚生省新药开发研究班,将抗癌药物装在极小的脂肪胶囊内,然后用来注射,证实其副作用大减,效果大为提高。具有代表性的抗癌剂阿霉素,是具有一定疗效的抗癌药,但由于对心脏有副作用,不能大量使用。采用上述新技术实验,证实对心脏的副作用减低到原来的三分之一;而达到癌细胞内的药量,却提高了一倍。 The Ministry of Health and Welfare of Japan, a research group for the development of new drugs, packed anti-cancer drugs into tiny fat capsules and used them to inject them, confirming that the side effects have been greatly reduced and the effect has been greatly improved. A typical anticancer agent, doxorubicin, is an anticancer drug with certain efficacy, but it cannot be used in large quantities due to adverse effects on the heart. Using the above-mentioned new technology experiments, it was confirmed that the side effects on the heart were reduced to one-third of the original; while the amount of drug in the cancer cells was doubled.